Form 8-K - Current report:
SEC Accession No. 0001193125-23-202314
Filing Date
2023-08-03
Accepted
2023-08-03 08:10:58
Documents
54
Period of Report
2023-08-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d870924d8k.htm   iXBRL 8-K 28086
2 EX-99.1 d870924dex991.htm EX-99.1 62805
3 EX-99.2 d870924dex992.htm EX-99.2 41992
7 GRAPHIC g870924ex99_2s10g1.jpg GRAPHIC 92447
8 GRAPHIC g870924ex99_2s11g1.jpg GRAPHIC 121219
9 GRAPHIC g870924ex99_2s12g1.jpg GRAPHIC 98980
10 GRAPHIC g870924ex99_2s13g1.jpg GRAPHIC 86821
11 GRAPHIC g870924ex99_2s14g1.jpg GRAPHIC 91732
12 GRAPHIC g870924ex99_2s15g1.jpg GRAPHIC 69987
13 GRAPHIC g870924ex99_2s16g1.jpg GRAPHIC 78953
14 GRAPHIC g870924ex99_2s17g1.jpg GRAPHIC 85816
15 GRAPHIC g870924ex99_2s18g1.jpg GRAPHIC 83227
16 GRAPHIC g870924ex99_2s19g1.jpg GRAPHIC 107561
17 GRAPHIC g870924ex99_2s1g1.jpg GRAPHIC 90226
18 GRAPHIC g870924ex99_2s20g1.jpg GRAPHIC 64217
19 GRAPHIC g870924ex99_2s21g1.jpg GRAPHIC 88933
20 GRAPHIC g870924ex99_2s22g1.jpg GRAPHIC 88130
21 GRAPHIC g870924ex99_2s23g1.jpg GRAPHIC 72485
22 GRAPHIC g870924ex99_2s24g1.jpg GRAPHIC 118327
23 GRAPHIC g870924ex99_2s25g1.jpg GRAPHIC 89955
24 GRAPHIC g870924ex99_2s26g1.jpg GRAPHIC 86776
25 GRAPHIC g870924ex99_2s27g1.jpg GRAPHIC 84625
26 GRAPHIC g870924ex99_2s28g1.jpg GRAPHIC 75103
27 GRAPHIC g870924ex99_2s29g1.jpg GRAPHIC 125224
28 GRAPHIC g870924ex99_2s2g1.jpg GRAPHIC 142972
29 GRAPHIC g870924ex99_2s30g1.jpg GRAPHIC 70905
30 GRAPHIC g870924ex99_2s31g1.jpg GRAPHIC 98028
31 GRAPHIC g870924ex99_2s32g1.jpg GRAPHIC 88291
32 GRAPHIC g870924ex99_2s33g1.jpg GRAPHIC 106205
33 GRAPHIC g870924ex99_2s34g1.jpg GRAPHIC 81527
34 GRAPHIC g870924ex99_2s35g1.jpg GRAPHIC 89612
35 GRAPHIC g870924ex99_2s36g1.jpg GRAPHIC 84634
36 GRAPHIC g870924ex99_2s37g1.jpg GRAPHIC 91137
37 GRAPHIC g870924ex99_2s38g1.jpg GRAPHIC 92539
38 GRAPHIC g870924ex99_2s39g1.jpg GRAPHIC 89091
39 GRAPHIC g870924ex99_2s3g1.jpg GRAPHIC 73313
40 GRAPHIC g870924ex99_2s4g1.jpg GRAPHIC 75099
41 GRAPHIC g870924ex99_2s5g1.jpg GRAPHIC 79945
42 GRAPHIC g870924ex99_2s6g1.jpg GRAPHIC 88074
43 GRAPHIC g870924ex99_2s7g1.jpg GRAPHIC 85539
44 GRAPHIC g870924ex99_2s8g1.jpg GRAPHIC 70444
45 GRAPHIC g870924ex99_2s9g1.jpg GRAPHIC 75608
46 GRAPHIC g870924g0802041440133.jpg GRAPHIC 3436
  Complete submission text file 0001193125-23-202314.txt   5088372

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA prld-20230803.xsd EX-101.SCH 2843
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE prld-20230803_lab.xml EX-101.LAB 17977
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prld-20230803_pre.xml EX-101.PRE 11253
48 EXTRACTED XBRL INSTANCE DOCUMENT d870924d8k_htm.xml XML 3399
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

EIN.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39527 | Film No.: 231138195
SIC: 2834 Pharmaceutical Preparations